All Clinical trials

Citations 341-350 of 604 total displayed.

Past content (since Jan 2000):

BRIEF COMMUNICATIONS
Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy

A. Iranzo, J. Santamaria, E. Tolosa, I. Vilaseca, F. Valldeoriola, M. J. Martí, and E. Muñoz
Neurology 2004; 63: 930-932. [Abstract] [Full text] [PDF]  

ARTICLES
Economic evaluation of donepezil in moderate to severe Alzheimer disease

H. Feldman, S. Gauthier, J. Hecker, B. Vellas, M. Hux, Y. Xu, E.M. Schwam, S. Shah, and V. Mastey
Neurology 2004; 63: 644-650. [Abstract] [Full text] [PDF]  

ARTICLES
Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial

S. Salloway, S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar, and S. Richardson
Neurology 2004; 63: 651-657. [Abstract] [Full text] [PDF]  

ARTICLES
Strength training and albuterol in facioscapulohumeral muscular dystrophy

E.L. van der Kooi, O.J.M. Vogels, R.J.G.P. van Asseldonk, E. Lindeman, J.C.M. Hendriks, M. Wohlgemuth, S.M. van der Maarel, and G.W. Padberg
Neurology 2004; 63: 702-708. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis

Margaret Lane, John McBride, and John Archer
Neurology 2004; 63: 713-714. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

Kenneth C. Gorson, Anthony A. Amato, and Allan H. Ropper
Neurology 2004; 63: 715-717. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Progression despite replacement of a myopathic form of coenzyme Q₁₀ defect

K. Auré, J. F. Benoist, H. Ogier de Baulny, N. B. Romero, O. Rigal, and A. Lombès
Neurology 2004; 63: 727-729. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Sustained remission of CIDP associated with Evans syndrome

Hans Knecht, Michael Baumberger, Aurelio Tobòn, and Andreas Steck
Neurology 2004; 63: 730-732. [Abstract] [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
Melatonin, 3 mg, is effective for migraine prevention

M. F.P. Peres, E. Zukerman, F. da Cunha Tanuri, F. R. Moreira, and J. Cipolla-Neto
Neurology 2004; 63: 757. [Full text] [PDF]  

ARTICLES
Predicting the response to sumatriptan: The Sumatriptan Naratriptan Aggregate Patient Database

Hans Christoph-Diener, Michel Ferrari, and Hank Mansbach
Neurology 2004; 63: 520-524. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61